344 related articles for article (PubMed ID: 15749671)
1. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
[TBL] [Abstract][Full Text] [Related]
2. [Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].
Cmunt E; Michalová K; Sindelárová L; Karban J; Zemanová Z; Kurková S; Brezinová J; Schwarz J; Bosáková Z
Sb Lek; 2002; 103(3):359-70. PubMed ID: 12688180
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
Molica S
Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
5. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification in chronic lymphocytic leukemia.
Seiler T; Döhner H; Stilgenbauer S
Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
[TBL] [Abstract][Full Text] [Related]
7. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
9. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
13. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapy for chronic lymphocytic leukaemia.
Auer RL; Gribben J; Cotter FE
Br J Haematol; 2007 Dec; 139(5):635-44. PubMed ID: 17961187
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
17. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
18. Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL).
Zenz T; Fröhling S; Mertens D; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2010 Mar; 23(1):71-84. PubMed ID: 20620972
[TBL] [Abstract][Full Text] [Related]
19. Prognostic markers in chronic lymphocytic leukaemia.
Hamblin TJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
[TBL] [Abstract][Full Text] [Related]
20. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
